Huib N. Caron cancer researcher
Caron, H.N. (Hubertus Nicolaas)
Caron, H.N.
VIAF ID: 289502719 (Personal)
Permalink: http://viaf.org/viaf/289502719
Preferred Forms
-
100 1 _
‡a
Caron, H.N.
-
100 1 _ ‡a Caron, H.N. ‡q (Hubertus Nicolaas)
-
100 0 _
‡a
Huib N. Caron
‡c
cancer researcher
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| Behandelingsstrategieën bij kinderen met verdenking op kanker |
|
| Cancer predisposition in children : genetics, phenotypes & screening |
|
| Childhood cancer treatment optimization : in rhabdomyosarcoma and supportive care |
|
| Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity |
|
| Evaluation of a patient information website for childhood cancer survivors |
|
| Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma |
|
| The guardians' perspective on paediatric cancer treatment in Malawi and factors affecting adherence |
|
| High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type |
|
| High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma |
|
| High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition |
|
| High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage |
|
| High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs |
|
| High risk of symptomatic cardiac events in childhood cancer survivors |
|
| Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. |
|
| Histone deacetylases (HDACs): characterization of the classical HDAC family |
|
| The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes |
|
| Identification of BIRC6 as a novel intervention target for neuroblastoma therapy |
|
| Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells |
|
| The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer |
|
| Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features |
|
| Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe |
|
| LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. |
|
| Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis |
|
| Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi |
|
| Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification |
|
| MIBG scintigraphy and PET imaging for diagnosing neuroblastoma |
|
| Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. |
|
| Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children |
|
| Moleculaire kinderoncologie : "Van gen naar genezing" |
|
| Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression |
|
| MON-458 Radiological Alterations Of The Hypothalamic-pituitary Region After Craniospinal Irradiation For Medulloblastoma During Childhood |
|
| The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. |
|
| Neuroblastoma: biology, prognosis, and treatment |
|
| Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients |
|
| Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours |
|
| NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome |
|
| Obituary of a very special doctor, Dr Jan de Kraker (October 18, 1944 to January 19, 2012). |
|
| Peripheral stem cell apheresis is feasible post Iodine-metaiodobenzylguanidine- therapy in high-risk neuroblastoma, but results in delayed platelet reconstitution |
|
| The Phox2B homeobox gene is mutated in sporadic neuroblastomas |
|
| The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification |
|
| Prevalence and patterns of morphological abnormalities in patients with childhood cancer |
|
| Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature. |
|
| Prevention of anthracycline-induced cardiotoxicity in children: the evidence |
|
| Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial |
|
| Prognostic factors for progression of childhood optic pathway glioma: a systematic review |
|
| Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids |
|
| QOS-48PREVALENCE AND RISK FACTORS OF EARLY ENDOCRINE DISORDERS IN CHILDHOOD BRAIN TUMOR SURVIVORS: A NATIONWIDE MULTICENTER STUDY. |
|
| Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma |
|
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations |
|
| Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors |
|
| Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: is it effective? |
|
| Response to "cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery". |
|
| Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells |
|
| Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis |
|
| The role of the 'innovative therapies for children with cancer' (ITCC) European consortium. |
|
| Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes |
|
| Should anthracyclines and dexrazoxane be used for children with cancer? |
|
| Social outcomes in adult survivors of childhood cancer compared to the general population: linkage of a cohort with population registers |
|
| Stability of PCR targets for monitoring minimal residual disease in neuroblastoma. |
|
| Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers |
|
| Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors |
|
| Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids |
|
| Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth |
|
| Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression |
|
| Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis |
|
| Treatment and outcome of neuroblastoma with intraspinal extension: A systematic review |
|
| Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer |
|
| Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan |
|
| The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment. |
|
| Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tan |
|
| Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study |
|
| Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma |
|
| A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. |
|
